PRRT2 and bipolar disorder: The mainstay treatment for bipolar disorder, lithium, exerts major effects on the PKC signaling cascade, for example by decreasing membrane-associated PKC, including isozyme-specific decreases in the classic PKCα and novel PKCε [335].